Related by context. Frequent words. (Click for all words.) 58 dose titration 56 Phase IIIb 56 phase IIa 55 phase Ib 55 Phase Ib II 55 Traficet EN 55 GSK# [001] 54 PA# [002] 54 Phase IIa clinical trials 54 ATL# [001] 54 nab paclitaxel 53 Phase Ib clinical 53 PEG SN# 53 DDP# 53 phase IIa clinical 53 phase IIb clinical 52 methylnaltrexone 52 interferon beta 1b 52 coadministration 52 goserelin 52 phase IIb 52 Phase Ia 51 squalamine 51 PEGPH# 51 pharmacokinetic studies 51 registrational 51 Investigational Device Exemption 51 tanespimycin 51 BEXXAR 51 ARIKACE 51 EOquin 51 pharmacokinetic PK 51 Fibrillex TM 51 SAR# [004] 51 Urocidin 51 rilonacept 51 forodesine 51 subcutaneous formulation 50 Alitretinoin 50 Board DSMB 50 Phase IIB 50 Randomized controlled 50 Neuradiab 50 MERLIN TIMI 50 QC QA 50 PROPEL trial 50 elotuzumab 50 Swastika Laboratories 50 clevudine 50 Phase 1b clinical 50 Phase 1a 50 QAQC 50 dose escalation 50 PMA submission 49 ezogabine 49 Confirmatory 49 mg kg dose 49 ISTODAX 49 blanks duplicates 49 Phase Ib 49 FavId 49 strict QA QC 48 CHMP recommendation 48 Diamyd ® 48 polysomnography 48 PROMACTA 48 IND Investigational New 48 prospectively defined 48 GLPG# 48 Phase 1b 48 Test Command JITC 48 QA QC protocols 48 histopathological 48 IND enabling 48 5 HT3 receptor 48 AlloMap 47 Phase III pivotal 47 confirmatory Phase III 47 IND submission 47 biostatistical 47 supplemental Biologics License Application 47 Phase 2a trial 47 hGH CTP 47 celgosivir 47 Amplimexon 47 Assayers Canada 47 tartrate 46 dacetuzumab 46 cangrelor 46 titration 46 BNC# 46 Significant intersections 46 Bicifadine 46 romidepsin 46 UL CSA 46 Virulizin R 46 dirucotide 46 IMC A# 46 SWOG 46 Secondary endpoints include 46 Phase IIb trials